{
    "2018-10-04": [
        [
            {
                "time": "2018-09-30",
                "original_text": "Top Performing ETFs of the Third Quarter",
                "features": {
                    "keywords": [
                        "ETFs",
                        "Third Quarter",
                        "Performance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-05",
                "original_text": "What AbbVie’s Valuation Trend Indicates",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Valuation",
                        "Trend"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-10",
                "original_text": "Seattle Genetics: Impact of the Cascadian Acquisition",
                "features": {
                    "keywords": [
                        "Seattle Genetics",
                        "Cascadian",
                        "Acquisition"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "Antares Pharma Is Expected to Report Positive EPS in 2019",
                "features": {
                    "keywords": [
                        "Antares Pharma",
                        "EPS",
                        "2019"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-10-20",
                "original_text": "5 Reasons Why Investors Should Bet on Pfizer (PFE) Stock",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Investors",
                        "Stock"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "J&J's Phase III Data Shows Switch to its HIV Drug Beneficial",
                "features": {
                    "keywords": [
                        "J&J",
                        "Phase III",
                        "HIV Drug"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Amgen’s Stock Performance and Estimates after Q3 2018",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Stock Performance",
                        "Q3 2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Better Buy: Gilead Sciences, Inc. vs. Pfizer",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "Pfizer",
                        "Better Buy"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-10",
                "original_text": "How Did Pfizer Stock Fare in Q3 2018?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock",
                        "Q3 2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "Eli Lilly’s Stock Performance and Estimates for Q3 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock Performance",
                        "Q3 2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-20",
                "original_text": "Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US",
                "features": {
                    "keywords": [
                        "Moody's",
                        "Biosimilars",
                        "Biotech Drugs",
                        "European Market"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            }
        ]
    ]
}